✓ Enriched with full company details from live data.
IndustryResearch
Employees11-50
HeadquartersSydney, New South Wales, Australia
Funding stageEquity Crowdfunding
Total funding$33M
LinkedIn followers7
Est. revenue$4M
EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.
Technology stack
Click any tool to see other companies using it.
🔥 24 people from EnGeneIC are searchable on evyAI — names, titles, and unlockable contact info.
Also appears in these lists
- Top 100 Companies Using Basis — 556,627 companies
- Top 100 Companies Using GoDaddy Hosting — 225,087 companies
- Top 100 Research in the United States — 90,138 companies